A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload

Transfusion Medicine Reviews

Volumn 27, Issue 4, 2013, Pages 206-212

  Lieberman, Lani ^a,b   Maskens, Carolyn ^c   Cserti Gazdewich, Christine ^a,b   Hansen, Mark ^d   Lin, Yulia ^b,d   Pendergrast, Jacob ^a,b   Yi, Qi Long ^e   Callum, Jeannie ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; CLINICAL FEATURE; COLLOID; CONGESTIVE HEART FAILURE; CRYSTALLOID; DEMOGRAPHY; ECHOCARDIOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INFUSION RATE; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; RADIOGRAPHY; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TREATMENT OUTCOME;

ADULT; AGED; BLOOD TRANSFUSION; COLLOIDS; CYANOSIS; DATABASES, FACTUAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84886748713     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.07.002     Document Type: Article

References (21)

1. Narick C., Triulzi D.J., Yazer M.H. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012, 52:160-165.
2. Popovsky M.A. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang 2004, 87(Suppl 2):62-65.
3. Bierbaum B.E., Callaghan J.J., Galante J.O., Rubash H.E., Tooms R.E., Welch R.B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2-10.
4. Rana R., Fernandez-Perez E.R., Khan S.A., Rana S., Winters J.L., Lesnick T.G., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006, 46:1478-1483.
5. Popovsky M.A., Audet A.M., Andrzejewski C. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996, 12:87-89.
6. Li G., Daniels C.E., Kojicic M., Krpata T., Wilson G.A., Winters J.L., et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009, 49:13-20.
7. Tobian A.A., Sokoll L.J., Tisch D.J., Ness P.M., Shan H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008, 48:1143-1150.
8. Li G., Rachmale S., Kojicic M., Shahjehan K., Malinchoc M., Kor D.J., et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011, 51:338-343.
9. Annual SHOT report 2012 summary Working Expert Group and Writing Group, (Accessed: July 30th 2013). http://www.shotuk.org/wp-content/uploads/SHOT-Summary-2012.pdf.
10. Robillard P.I., Karl N., Chapdelaine A. Nine-year trends in incidence of adverse transfusion reactions with respiratory complications in Quebec Hemovigilance System. Transfusion 2010, 50:11A-12A.
11. U.S.Food and Drug Administration Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012 (Accessed: July 30th 2013). http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm.
12. Balegar V.K., Kluckow M. Furosemide for packed red cell transfusion in preterm infants: a randomized controlled trial. J Pediatr 2011, 159:913 e911-918 e911.
13. Gupta S.P., Nand N., Gupta M.S. Left ventricular filling pressures after rapid blood transfusion in cases of chronic severe anemia. Angiology 1982, 33:343-348.
14. Andrzejewski C., Popovsky M.A. Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 2005, 45:1048-1050.
15. Transfusion Transmitted Injuries Surveillance Section. Blood Safety Surveillance and Health Care Acquired Infections Division. Transfusion transmitted injuries surveillance system program report 2004-2005 http://www.phac-aspc.gc.ca/hcai-iamss/tti-it/tti_report-eng.php.
16. Alam A., Lin Y., Lima A., Hansen M., Callum J.L. The prevention of transfusion-associated circulatory overload. Transfus Med Rev 2013, 27:105-112.
17. Li G., Kojicic M., Reriani M.K., Fernandez Perez E.R., Thakur L., Kashyap R., et al. Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest 2010, 137:783-789.
18. Murphy E.L., Kwaan N., Looney M.R., Gajic O., Hubmayr R.D., Gropper M.A., et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 2013, 126:357.e329-357.e338.
19. Popovsky M., Taswell H.F. Circulatory overload: an underdiagnosed consequence of transfusion (abstract). Transfusion 1985, 25:469.
20. Andrzejewski C., Popovsky M.A., Stec T.C., Provencher J., O'Hearn L., Visintainer P., et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?. Transfusion 2012, 52:2310-2320.
21. Zhou L., Giacherio D., Cooling L., Davenport R.D. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005, 45:1056-1063.